OtherBASIC SCIENCE INVESTIGATIONS
Preparation and Biological Evaluation of 64Cu-CB-TE2A-sst2-ANT, a Somatostatin Antagonist for PET Imaging of Somatostatin Receptor–Positive Tumors
Thaddeus J. Wadas, Martin Eiblmaier, Alexander Zheleznyak, Christopher D. Sherman, Riccardo Ferdani, Kexian Liang, Samuel Achilefu and Carolyn J. Anderson
Journal of Nuclear Medicine November 2008, 49 (11) 1819-1827; DOI: https://doi.org/10.2967/jnumed.108.054502
Thaddeus J. Wadas
Martin Eiblmaier
Alexander Zheleznyak
Christopher D. Sherman
Riccardo Ferdani
Kexian Liang
Samuel Achilefu
Data supplements
Supplemental Data
Files in this Data Supplement:
In this issue
Journal of Nuclear Medicine
Vol. 49, Issue 11
November 2008
Preparation and Biological Evaluation of 64Cu-CB-TE2A-sst2-ANT, a Somatostatin Antagonist for PET Imaging of Somatostatin Receptor–Positive Tumors
Thaddeus J. Wadas, Martin Eiblmaier, Alexander Zheleznyak, Christopher D. Sherman, Riccardo Ferdani, Kexian Liang, Samuel Achilefu, Carolyn J. Anderson
Journal of Nuclear Medicine Nov 2008, 49 (11) 1819-1827; DOI: 10.2967/jnumed.108.054502
Preparation and Biological Evaluation of 64Cu-CB-TE2A-sst2-ANT, a Somatostatin Antagonist for PET Imaging of Somatostatin Receptor–Positive Tumors
Thaddeus J. Wadas, Martin Eiblmaier, Alexander Zheleznyak, Christopher D. Sherman, Riccardo Ferdani, Kexian Liang, Samuel Achilefu, Carolyn J. Anderson
Journal of Nuclear Medicine Nov 2008, 49 (11) 1819-1827; DOI: 10.2967/jnumed.108.054502
Jump to section
Related Articles
Cited By...
- Somatostatin Receptor Antagonists for Imaging and Therapy
- N-Terminal Modifications Improve the Receptor Affinity and Pharmacokinetics of Radiolabeled Peptidic Gastrin-Releasing Peptide Receptor Antagonists: Examples of 68Ga- and 64Cu-Labeled Peptides for PET Imaging
- Promises of Cyclotron-Produced 44Sc as a Diagnostic Match for Trivalent {beta}--Emitters: In Vitro and In Vivo Study of a 44Sc-DOTA-Folate Conjugate
- Positron-emission Tomography (PET) Imaging Agents for Diagnosis of Human Prostate Cancer: Agonist vs. Antagonist Ligands
- PET of Somatostatin Receptor-Positive Tumors Using 64Cu- and 68Ga-Somatostatin Antagonists: The Chelate Makes the Difference
- Small-Animal PET of Tumors with 64Cu-Labeled RGD-Bombesin Heterodimer